| Total | Agree (%) | Neutral (%) | Disagree (%) | p-value | |
|---|---|---|---|---|---|
| 1. Drug Company trials vs government supported trials | 73 | 26 (35.6) | 34 (46.6) | 34 (46.6) | 0.0071 |
| 2. Promising new drug not knowing effect (phase 1) | 77 | 28 (36.4) | 21 (27.3) | 28 (36.4) | 0.5176 |
| 3. Information on clinical trials | 78 | 51 (65.4) | 12(15.4) | 15(19.2) | <0.0001 |
| 4. Randomized trials-“Flipping a coin” or “throwing a dice” | 77 | 15 (19.5) | 15 (19.5) | 47 (61) | <0.0001 |
| 5. Clinical trial as first line option | 76 | 17 (22.4) | 22 (28.9) | 37 (48.7) | 0.0161 |
| 6. Clinical trial after first line treatment failed | 77 | 33 (42.9) | 23 (29.9) | 21 (27.3) | 0.2109 |
| 7. Clinical trial for benefit of others | 77 | 33 (42.9) | 25 (32.5) | 19 (24.7) | 0.1464 |
| 8. Participate in trials even if more time consuming or additional tests | 75 | 30 (40) | 20 (26.7) | 25 (33.3) | 0.3654 |
| 9. Privacy protection by the university | 74 | 42 (56.8) | 19 (25.7) | 13 (17.6) | <0.0001 |
| 10. Safety by University sponsored trial | 74 | 38 (51.4) | 19 (25.7) | 17 (23) | 0.0059 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.